Sunstone Hotel Investors, Inc. SHO 深 滬
等待開盤 08-14 09:30:00 美东时间
9.24
+0.240
+2.67%
華盛通- 最 高9.275
- 今 開9.00
- 成交量 140.55万股
- 最 低 8.99
- 昨 收 9.00
- 總市值 18.39亿
- 52周最高 12.14
- 市盈率 靜 67.45
- 換手率 0.71%
- 52周最低 7.36
- 委 比 40.85%
- 總股本 1.99亿
- 歷史最高 15.25
- 量 比 0.52
- 振 幅 3.17%
- 歷史最低 -0.89
- 每 手 1
- 風險率 1.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sunstone Hotel declares $0.09 dividend
Sunstone Hotel (NYSE:SHO) declares $0.09/share quarterly dividend, in line with previous. Forward yield 4.22% Payable Oct. 15; for shareholders of record Sept. 30; ex-div Sept. 30. See SHO Dividend Sc...
08-06 21:46
Sunstone Hotel Invts Lowers FY2025 FFO Guidance from $0.82-$0.94 to $0.80-$0.87 vs $0.90 Est
Sunstone Hotel Invts (NYSE:SHO) lowers FY2025 FFO guidance from $0.82-$0.94 to $0.80-$0.87 vs $0.90 analyst estimate..
08-06 19:31
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
SportsHero Limited Addresses ASX Price Query Amid Early-Stage Discussions
The latest update is out from SportsHero Limited ( ($AU:SHO) ). SportsHero Limi...
08-06 16:23
经济研究：欧元区经济运行良好 下次降息可能会在12月
欧洲央行似乎并不急于通过放松货币政策来应对欧元区经济面临的种种阻力。彭博经济研究认为，近期数据显示，尽管与美国的贸易争端仍在持续，但欧元区经济仍保持良好，因...
08-06 14:24
ABRDN JAPAN EQUITY FUND, INC. (JEQ) ANNOUNCES COMMENCEMENT OF 50% CASH TENDER OFFER
PHILADELPHIA, Aug. 1, 2025 /PRNewswire/ -- abrdn Japan Equity Fund, Inc. (NYSE: JEQ), a diversified management investment company, announced today the commencement of the previously disclose...
08-02 04:17
SportsHero Expands Gaming Footprint in Southeast Asia
The latest announcement is out from SportsHero Limited ( ($AU:SHO) ). SportsHer...
07-31 15:47
Where Sunstone Hotel Invts Stands With Analysts
Across the recent three months, 4 analysts have shared their insights on Sunsto...
07-28 21:00
Evercore ISI Group Maintains Outperform on Sunstone Hotel Invts, Raises Price Target to $11
Evercore ISI Group analyst Duane Pfenningwerth maintains Sunstone Hotel Invts (NYSE:SHO) with a Outperform and raises the price target from $10 to $11.
07-28 20:52
Ascendis Pharma Secures FDA Approval For SKYTROFA To Treat Adult Growth Hormone Deficiency
First of many planned label expansions supporting Vision 2030 goal to become the leading endocrinology rare disease companyOn track to initiate basket trial for ISS, SHOX deficiency, Turner syndrome, and SGA*, as
07-28 19:08
